Next Post

Amarin launches Vascepa in all-crucial Europe as it bit by bit bleeds share to U.S. generic

A drug’s EU launch seldom results in being a lot more critical than its U.S. rollout from a industry opportunity standpoint, but that’s specifically what is taking place to Amarin’s fish oil-derived coronary heart drug Vascepa. Amarin has began prepping gross sales reps in Germany for the prepared start of […]

Subscribe US Now